Long-term biological complications of dental implants placed either in pristine or in augmented sites: A systematic review and meta-analysis. by Salvi, Giovanni Edoardo et al.
294  |    Clin Oral Impl Res. 2018;29(Suppl. 16):294–310.wileyonlinelibrary.com/journal/clr
 
Accepted: 12 December 2017
DOI: 10.1111/clr.13123
R E V I E W  A R T I C L E
Long- term biological complications of dental implants placed 
either in pristine or in augmented sites: A systematic review 
and meta- analysis
Giovanni E. Salvi1  | Alberto Monje2  | Cristiano Tomasi3
1Department of Periodontology, School of 
Dental Medicine, University of Bern, Bern, 
Switzerland
2Department of Oral Surgery and 
Stomatology, School of Dental 
Medicine, University of Bern, Bern, 
Switzerland
3Department of Periodontology, Institute 
of Odontology, The Sahlgrenska Academy 
at University of Gothenburg, Gothenburg, 
Sweden
Correspondence
Giovanni E. Salvi, Department of 
Periodontology, School of Dental Medicine, 
University of Bern, Bern, Switzerland.
Email: giovanni.salvi@zmk.unibe.ch
Abstract
Aim: To investigate and compare the prevalence of biological complications and failure 
of implants placed in pristine vs. augmented sites after a mean observation period of 
at least 10 years.
Materials and methods: The focused question “In patients with osseointegrated dental 
implants, are there differences in biological complications and implant failure at 
implants placed in pristine vs. augmented sites?” was addressed using the Population, 
Exposure, Comparison and Outcome criteria. Electronic and manual searches 
supplemented by the screening of the grey literature were carried out. A case definition 
of peri- implant mucositis and peri- implantitis had to be specified. The binary random- 
effects method was chosen to conduct meta- analyses. Results are presented as Forest 
plots with weighted mean values and 95% confidence intervals (CI). The I2 statistic test 
was applied to quantify heterogeneity. The Newcastle- Ottawa Scale and the 
parameters provided in the Cochrane Center and CONSORT statement were used for 
quality assessment. The results are reported according to the PRISMA guidelines.
Results: No randomized clinical trial (RCT) comparing the outcomes of implants placed 
in pristine vs. augmented sites was identified. Five case- series studies, one case–
control study, one cross- sectional study and one RCT were eligible for qualitative and 
quantitative analyses. No statistically significant differences (p > .05) were observed 
between implants placed in pristine vs. augmented sites for any outcome variables 
both at patient and at implant levels, respectively. High heterogeneity concerning 
patient sampling, case definitions of biological complications and eligibility criteria was 
observed.
Conclusion: The studies included in the present systematic review did not directly 
address the focused questions. Hence, the outcomes of the meta- analysis should be 
interpreted with caution due to high variability with respect to study design.
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1  | INTRODUCTION
Outcomes from preclinical studies indicated that the alveolar ridge un-
dergoes resorptive processes following tooth extraction impacting on 
the bony envelope for an ideal prosthetically driven implant placement 
(Araújo & Lindhe, 2005).
Findings in posterior extraction sites demonstrated that within 
1 year, half of the alveolar ridge width is resorbed, of which 2/3 oc-
curred during the first 3 months (Schropp, Wenzel, Kostopoulos, & 
Karring, 2003). Moreover, results from clinical studies showed a sub-
stantial amount of vertical bone resorption on the vestibular aspect of 
the alveolar process (Araújo & Lindhe, 2005; Cardaropoli, Araújo, & 
Lindhe, 2003; Chappuis et al., 2015). Interestingly, thickening of the 
soft tissue following tooth extraction was observed in sites with a facial 
alveolar bone thickness < 1 mm masking underlying bone deficiencies 
(Chappuis, Bornstein, Buser, & Belser, 2016). This fact may severely 
compromise optimal three- dimensional implant positioning (Atwood, 
1971, 1973). Therefore, in order to achieve primary implant stability 
and successful osseointegration, simultaneous or staged lateral and/
or vertical bone augmentation procedures are needed to manage the 
reconstruction of atrophic alveolar ridges (Milinkovic & Cordaro, 2014; 
Urban et al., 2016). Based on recent advances in regenerative tech-
nologies, bone augmentation procedures are nowadays performed 
with minor invasiveness due to the use of bone substitutes and barrier 
membranes (Kuchler & von Arx, 2014).
Recently, controversial data on the long- term survival rates of 
implants placed in augmented vs. pristine bone have been reported 
(Chappuis, Cavusoglu, Buser, & von Arx, 2017; Daubert, Weinstein, 
Bordin, Leroux, & Flemmig, 2015; Tran et al., 2016; Urban et al., 2016; 
Visser, Stellingsma, Raghoebar, Meijer, & Vissink, 2016). For example, 
while some studies showed comparable outcomes in terms of implant 
survival rates and crestal bone loss (Chappuis et al., 2017; Urban et al., 
2016), other studies reported inferior outcomes for implants placed in 
augmented sites (Daubert et al., 2015; Tran et al., 2016; Visser et al., 
2016).
A recent systematic review with meta- analysis reported subject- 
based estimated weighted mean prevalences and ranges for peri- 
implant diseases derived from longitudinal studies (Derks & Tomasi, 
2015). The prevalence for peri- implant mucositis amounted to 43% 
ranging from 19% to 65% and for peri- implantitis to 22% ranging from 
1% to 47%, respectively (Derks & Tomasi, 2015). Moreover, several 
cross- sectional studies reported comparable data to those conducted 
in longitudinal ones (Aguirre- Zorzano, Estefania- Fresco, Telletxea, & 
Bravo, 2015; Dalago, Schuldt Filho, Rodrigues, Renvert, & Bianchini, 
2017; Daubert et al., 2015; Konstantinidis, Kotsakis, Gerdes, & Walter, 
2015; Monje, Wang, & Nart, 2017; Rokn et al., 2017; Schwarz et al., 
2017).
Despite the fact that placement of dental implants in conjunction 
with augmentation procedures is well documented and was shown to 
yield high predictability in terms of implant survival rates and volume 
stability (Buser et al., 2013; Elnayef et al., 2017), comparative knowl-
edge between the long- term prevalence of biological complications at 
implants placed in pristine vs. augmented sites is lacking.
Hence, the aim of the present systematic review was to investigate 
and compare the prevalence of biological complications and failure of 
implants placed in pristine vs. augmented sites after a mean observa-
tion period of at least 10 years.
2  | MATERIAL AND METHODS
2.1 | Study registration
The review protocol was registered and allocated the identification 
number CRD42017049602 in the PROSPERO international prospec-
tive register of systematic reviews hosted by the National Institute for 
Health Research (NIHR), University of York, UK, Center for Reviews 
and Dissemination.
2.2 | Reporting format
The Preferred Reporting Items for Systematic Reviews and Meta- Analyses 
(PRISMA) were adopted throughout the process of the present system-
atic review (Moher, Liberati, Tetzlaff, & Altman, 2009; Moher et al., 2015).
2.3 | Population (P), exposure (E), comparison (C) and 
outcomes (O) (PECO)
2.3.1 | Population
Edentulous and partially edentulous patients with osseointegrated ti-
tanium/titanium alloy dental implants.
2.3.2 | Exposure
Dental implants placed in augmented sites prior or simultaneous to 
implant placement, including alveolar ridge preservation and/or verti-
cal/lateral ridge augmentation.
2.3.3 | Comparison
Dental implants placed in sites not requiring augmentation procedures 
prior to or in conjunction with implant placement (i.e. pristine sites).
2.3.4 | Outcome
Primary outcome: Prevalence of biological complications (i.e., peri- 
implant mucositis and peri- implantitis).
Secondary outcome: Prevalence of implant failure (i.e. implant loss).
2.4 | Focused questions
The focused questions were adapted using the PECO criteria (Stone, 
2002).
Primary outcome: In patients with osseointegrated dental implants, 
are there differences in biological complications at implants placed in 
pristine vs. augmented sites?
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Secondary outcome: In patients with osseointegrated dental im-
plants, are there differences in failure rates of implants placed in pris-
tine vs. augmented sites?
2.5 | Search strategy
2.5.1 | Electronic search
A comprehensive and systematic electronic search of MEDLINE 
via PubMed, EMBASE via Ovid and Cochrane Central Register of 
Controlled Trials (CENTRAL) databases was conducted for articles 
published in the dental literature in English, German, French, Italian, 
Spanish and Portuguese up to 8 April 2017.
For the search in the PubMed library, combinations of controlled 
terms (MeSH and EMTREE) and keywords were used whenever possible.
For additional searches, terms not indexed as MeSH and filters 
were also applied:
((“bone and bones”[MeSH Terms] OR (“bone”[All Fields] AND 
“bones”[All Fields]) OR “bone and bones”[All Fields] OR “bone”[All 
Fields]) AND augmentation[All Fields]) AND (“dental health ser-
vices”[MeSH Terms] OR (“dental”[All Fields] AND “health”[All Fields] 
AND “services”[All Fields]) OR “dental health services”[All Fields] OR 
“dental”[All Fields]) AND implant[All Fields] AND (10[All Fields] AND 
years[All Fields]) AND “humans”[MeSH Terms]
(“bone regeneration”[MeSH Terms] OR (“bone”[All Fields] AND “re-
generation”[All Fields]) OR “bone regeneration”[All Fields]) AND (“den-
tal implants”[MeSH Terms] OR (“dental”[All Fields] AND “implants”[All 
Fields]) OR “dental implants”[All Fields] OR (“dental”[All Fields] AND 
“implant”[All Fields]) OR “dental implant”[All Fields]) AND (“long”[All 
Fields] AND (“term”[MeSH Terms] OR (“term”[All Fields]) OR “term”[All 
Fields]) AND “humans”[MeSH Terms]
(((((“dental implants”[MeSH Terms] OR “dental implantation, 
endosseous”[MeSH Terms]) AND long- term[Title/Abstract]) OR 
10 years[Title/Abstract]) AND peri- implant diseases[Title/Abstract]) 
OR peri- implantitis[Title/Abstract]) AND mucositis[Title/Abstract] OR 
peri- implant mucositis[Title/Abstract]
(implant[All Fields] AND (“dental health services”[MeSH Terms] OR 
(“dental”[All Fields] AND “health”[All Fields] AND “services”[All Fields]) 
OR “dental health services”[All Fields] OR “dental”[All Fields]) AND 
10[All Fields] AND year[All Fields]) AND ((Clinical Trial[ptyp] OR Clinical 
Study[ptyp] OR Case Reports[ptyp] OR Controlled Clinical Trial[ptyp] 
OR Randomized Controlled Trial[ptyp]) AND “humans”[MeSH Terms])
2.5.2 | Manual search
A manual search of the reference lists of relevant articles published 
in the Journal of Periodontology, Journal of Oral Rehabilitation, Journal 
of Clinical Periodontology, Clinical Oral Implants Research, International 
Journal of Oral & Maxillofacial Implants, Implant Dentistry, Clinical Implant 
Dentistry and Related Research, International Journal of Periodontics and 
Restorative Dentistry and the International Journal of Prosthodontics of 
the last 3 years was performed.
2.5.3 | Unpublished literature search
In order to further identify potential articles for inclusion, grey litera-
ture was searched in the register of clinical studies hosted by the US 
National Institutes of Health (www.clinicaltrials.gov) and in the multi-
disciplinary European database (www.opengrey.eu).
2.6 | Study selection
2.6.1 | Inclusion criteria
The following inclusion criteria were applied:
• Clinical studies with all levels of evidence
• Case series with ≥ 20 patients at baseline
• Studies reporting on titanium/titanium alloy implants
• Studies with a mean follow-up ≥ 10 years
• Studies reporting on lateral and/or vertical augmentation proce-
dures before or at time of implant placement
• Studies reporting on alveolar ridge preservation before implant 
placement
• Clinical and radiographic examinations at follow-up
• Studies including case definitions of peri-implant mucositis and 
peri-implantitis
2.6.2 | Exclusion criteria
The following exclusion criteria were applied:
• Preclinical studies
• Narrative reviews
• Abstracts
• Letters to editors
• Studies reporting on zirconia implants
• Studies reporting on early implant losses/complications (i.e., before 
implant loading)
• Studies reporting on augmentation procedures in the sinus cavity
• Studies reporting on zygomatic implants
• Studies reporting on tilted implants
• Studies reporting on distraction osteogenesis
• Studies reporting on subperiosteal implants
• Studies reporting on bicortical implants
• Studies reporting on hollow-cylinder and hollow-screw implants
• Studies reporting on patients taking medications/therapy affecting 
bone metabolism (i.e., bisphosphonates, radiation therapy)
• Studies reporting on patients with pathologies affecting bone me-
tabolism (i.e., osteoporosis, osteopenia, rheumatoid arthritis)
• Studies reporting on implants placed in sites affected by tumours
• Lack of information on whether augmentation procedures were 
performed or not
• Studies reporting on multiple augmentation procedures in which 
insufficient information is available to sort the data
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• Insufficient/unclear information on clinical and/or radiographic pa-
rameters leading to a case definition of peri-implant mucositis and 
peri-implantitis
• No author response to inquiry email for data clarification
Screening was performed independently by two reviewers 
(G.E.S. and A. M.). A third reviewer (C. T.) screened the selected full- 
text articles for consistency of the findings. A Cohen kappa score 
was calculated to assess interexaminer agreement (Landis & Koch, 
1977). Eligibility assessment was performed firstly through titles and 
abstract analysis and secondly through full- text analysis. In order to 
avoid exclusion of potentially relevant articles, abstracts providing 
unclear results were included in the full- text analysis. If necessary, 
authors were contacted for clarifications. From all studies of poten-
tial relevance, full text was obtained for independent assessment 
by the two reviewers against the stated inclusion criteria. Any dis-
agreement was resolved by discussion among the three reviewers. 
In the event of multiple publications on the same patient sample, 
relevant data on the primary and secondary outcome measures were 
extracted from the publication with a mean follow- up ≥ 10 years.
2.7 | Data collection
From the selected articles fulfilling the inclusion criteria, data address-
ing the primary and secondary outcome measures were extracted for 
analysis.
2.8 | Quality assessment
The Newcastle- Ottawa Scale (NOS) for assessing the quality of non- 
randomized, non- interventional studies was applied (Wells et al., 2011). 
The topics evaluated were selection of study groups, comparability of 
participants and outcome. Each included study received a maximum of 
13 points for cohort studies and of 10 points in case–control studies.
The criteria used to evaluate the quality of the selected random-
ized controlled trials (RCTs) derived from the randomized clinical trial 
checklist of the Cochrane Center and the CONSORT (Consolidated 
Standards of Reporting Trials) statement, providing guidelines for the 
following parameters: (i) sequence generation; (ii) allocation conceal-
ment method; (iii) masking of the examiner; (iv) address of incomplete 
outcome data; and (v) free of selective outcome reporting. The degree 
of bias was categorized as low risk if all the criteria were met, mod-
erate risk when only one criterion was missing and high risk if two or 
more criteria were missing (Moher et al., 2015; Schulz, Altman, Moher, 
& Fergusson, 2010).
2.9 | Data synthesis
Preliminary evaluation of the selected publications revealed consider-
able heterogeneity between the studies with respect to design and 
sample characteristics. Consequently, a qualitative report of the data 
was planned by applying descriptive methods and, if possible, a quan-
titative data synthesis for meta- analyses was applied.
2.10 | Data analysis
The I2 statistic test was applied to quantify heterogeneity among 
studies. After grouping data with respect to the use or not of an 
augmentation procedure, meta- analyses were performed to es-
timate overall prevalence at patient and at implant levels for 
the following outcomes: peri- implant mucositis, peri- implantitis 
and implant failure, using a specific software for meta- analysis 
(OpenMeta[Analyst]) (open source software, Brown University of 
Public Health, RI, USA). The binary random- effects method was 
chosen. Results are presented as Forest plots with weighted mean 
values and 95% confidence intervals (CI). A p value <.05 was consid-
ered statistically significant.
3  | RESULTS
3.1 | Study selection
A total of 852 records were identified through the electronic search 
and supplemented with 32 citations from the manual search and 
through screening of bibliographies of relevant included/excluded 
articles for a total of 864 citations following removal of duplicates 
(Figure 1).
Upon exclusion of 692 publications based on their titles, 172 stud-
ies remained for full- text evaluation. Following exclusion of 130 stud-
ies based on abstract, 42 studies remained. Finally, based on full- text 
assessment, 34 studies were excluded (Table 1) yielding eight studies 
(Daubert et al., 2015; Donati, Ekestubbe, Lindhe, & Wennström, 2016; 
Roccuzzo, Bonino, Dalmasso, & Aglietta, 2014; Roccuzzo, Gaudioso, 
Bunino, & Dalmasso, 2014; Roccuzzo, Savoini, Dalmasso, & Ramieri, 
2017; Simion, Ferrantino, Idotta, & Zarone, 2016; Tenenbaum et al., 
2017; Zuffetti et al., 2016) for qualitative synthesis. Out of the final 
eight publications, four evaluated the prevalence of peri- implant dis-
eases around implants placed in pristine sites (Donati et al., 2016; 
Roccuzzo, Bonino, et al., 2014; Tenenbaum et al., 2017; Zuffetti et al., 
2016) (Table 2a), three in augmented sites (Roccuzzo, Gaudioso, et al., 
2014; Roccuzzo et al. 2017; Simion et al., 2016) (Table 2b) and one in 
both pristine and augmented sites (Daubert et al., 2015), respectively 
(Table 2c). An interexaminer Cohen’s kappa score of 0.93 was calculated.
3.2 | Meta- analyses
Data were extracted from the selected papers and grouped according 
to patient characteristics as reported in the articles (i.e., periodontal 
conditions, smoking history, adherence to supportive periodontal 
therapy, loading time). The presence or absence of an augmentation 
procedure was used as a covariate for the analysis.
3.3 | Prevalence of biological complications and 
implant failure
The number of events on the total number observed for reported 
biological complications was entered in the meta- analysis software. Six 
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publications provided data for estimating prevalence of peri- implant 
mucositis at patient level (Roccuzzo, Bonino, et al., 2014; Roccuzzo, 
Gaudioso, et al., 2014; Roccuzzo et al. 2017; Simion et al., 2016; 
Tenenbaum et al., 2017; Zuffetti et al., 2016). In those publications, 
data were reported according to subgrouping, resulting in seven 
clusters for patients with pristine and three clusters for patients with 
augmented sites, respectively.
Seven publications provided data on the prevalence of peri- 
implantitis at patient level (Donati et al., 2016; Roccuzzo, Bonino, 
et al., 2014; Roccuzzo, Gaudioso, et al., 2014; Roccuzzo et al. 2017; 
Simion et al., 2016; Tenenbaum et al., 2017; Zuffetti et al., 2016). 
Subgroup analysis resulted in eight clusters for patients with pristine 
and three clusters for augmented sites, respectively.
Seven publications provided data on mucositis and on peri- 
implantitis at implant level (Daubert et al., 2015; Donati et al., 2016; 
Roccuzzo, Gaudioso, et al., 2014; Roccuzzo et al. 2017; Simion et al., 
2016; Tenenbaum et al., 2017; Zuffetti et al., 2016), with six clusters 
for pristine and four clusters for augmented sites, respectively.
Data on implant failure at patient level could be extracted from 
seven publications (Donati et al., 2016; Roccuzzo, Bonino, et al., 
2014; Roccuzzo, Gaudioso, et al., 2014; Roccuzzo et al. 2017; 
Simion et al., 2016; Tenenbaum et al., 2017; Zuffetti et al., 2016), 
with eight groups for pristine sites and three groups for augmented 
sites, while six publications provided data for failure at implant level 
(Daubert et al., 2015; Donati et al., 2016; Roccuzzo, Bonino, et al., 
2014; Roccuzzo et al. 2017; Tenenbaum et al., 2017; Zuffetti et al., 
2016), with nine groups for pristine and two for augmented sites, 
respectively.
3.4 | Meta- analyses at patient level
3.4.1 | Peri- implant mucositis
The total number of patients observed was 321, 242 for pristine sites 
and 79 for augmented sites. The meta- analysis of prevalence of peri- 
implant mucositis at patient level yielded weighted mean values of 
22.4% (95% CI 6%–38%) for pristine and of 19.6% (95% CI 0%–40%) 
for augmented sites, respectively. Heterogeneity as expressed by the 
I2 test was 93% for pristine and 88% for augmented sites, respectively 
(Figure 2).
F IGURE  1 Flow diagram of the systematic review
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3.4.2 | Peri- implantitis
The total number of patients observed was 351, 272 for pristine 
sites and 79 for augmented sites. The prevalence of peri- implantitis 
at patient level was estimated to a weighted mean of 10.3% (95% 
CI 4%–17%) for pristine sites and of 17.8% (95% CI 0%–37%) for 
augmented sites. Heterogeneity as expressed by the I2 test was 80% 
for pristine and 87% for augmented sites, respectively (Figure 3).
TABLE  1 List of excluded publications based on full- text 
assessment and reasons for exclusion
Publication Reason for exclusion
Karoussis et al. (2003) Lack of information on whether 
augmentation procedures were 
performed or not
Karoussis et al. (2004) Lack of information on whether 
augmentation procedures were 
performed or not
Fransson, Lekholm, Jemt, 
and Berglundh (2005)
Mean follow- up <10 years
Roos- Jansåker, Lindahl, 
Renvert, and Renvert 
(2006a)
Lack of information on whether 
augmentation procedures were 
performed or not
Roos- Jansåker, Lindahl, 
Renvert, and Renvert 
(2006b)
Lack of information on whether 
augmentation procedures were 
performed or not
Roos- Jansåker, Renvert, 
Lindahl, and Renvert 
(2006c)
Lack of information on whether 
augmentation procedures were 
performed or not
Renvert, Roos- Jansåker, 
Lindahl, Renvert, and 
Persson (2007)
Lack of information on whether 
augmentation procedures were 
performed or not
Fransson, Wennström, 
and Berglundh (2008)
Mean follow- up <10 years
Fransson, Wennström, 
Tomasi, and Berglundh 
(2009)
Mean follow- up <10 years
Fransson et al. (2010) Lack of information on clinical 
parameters for a case definition of 
peri- implantitis
Bonde, Stokholm, Isidor, 
and Schou (2010)
Lack of comparison between augmented 
and pristine sites with respect to 
biological complications or implant 
failure
Simonis, Dufour, and 
Tenenbaum (2010)
Lack of information on whether 
augmentation procedures were 
performed or not
Fischer and Stenberg 
(2012)
Lack of comparison between augmented 
and pristine sites with respect to 
biological complications or implant 
failure
Renvert, Lindahl, and 
Persson (2012)
Lack of information on whether 
augmentation procedures were 
performed or not
Gotfredsen (2012) Lack of information on whether 
augmentation procedures were 
performed or not
Swierkot, Lottholz, 
Flores- de- Jacoby, and 
Mengel (2012)
Insufficient information for data 
extraction
Stoker, van Waas, and 
Wismeijer (2012)
Lack of information on whether 
augmentation procedures were 
performed or not
Frisch, Ziebolz, and Rinke 
(2013)
Lack of information on whether 
augmentation procedures were 
performed or not
(Continues)
Publication Reason for exclusion
Lehmann et al. (2013) Sinus floor elevation and insufficient 
information for data extraction
Cecchinato, Parpaiola, 
and Lindhe (2014)
Lack of information on whether 
augmentation procedures were 
performed or not
Schropp, Wenzel, and 
Stavropoulos (2014)
Lack of information on whether 
augmentation procedures were 
performed or not
Mangano et al. (2014) Lack of information on whether 
augmentation procedures were 
performed or not
Meijer, Raghoebar, de 
Waal, and Vissink (2014)
Lack of information on whether 
augmentation procedures were 
performed or not
Meyle, Gersok, Boedeker, 
and Gonzales (2014)
Lack of information on whether 
augmentation procedures were 
performed or not
Renvert, Aghazadeh, 
Hallström, and Persson 
(2014)
Lack of information on whether 
augmentation procedures were 
performed or not
Trullenque- Eriksson and 
Guisado Moya (2014)
Lack of information on whether 
augmentation procedures were 
performed or not
Trullenque- Eriksson and 
Guisado Moya (2015)
Lack of information on whether 
augmentation procedures were 
performed or not
Frisch, Ziebolz, Vach, and 
Ratka- Krüger (2015)
Lack of information on whether 
augmentation procedures were 
performed or not
French, Larjava, and Ofec 
(2015)
Insufficient information for data 
extraction
van Velzen, Ofec, 
Schulten, and Ten 
Bruggenkate (2015)
No information on clinical parameters 
for a case definition of peri- implantitis
Woelber, Ratka- Krueger, 
Vach, and Frisch (2016)
Lack of information on whether 
augmentation procedures were 
performed or not
Jemt, Karouni, Abitbol, 
Zouiten, and Antoun 
(2017)
Insufficient information for data 
extraction
Urban, Monje, Lozada, 
and Wang (2017)
Lack of information on clinical 
parameters for a case definition of 
peri- implantitis
Gurgel et al. (2017) Insufficient information for data 
extraction
TABLE  1  (Continued)
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TABLE  2 Characteristics of the included studies on implants placed in (a) pristine sites, (b) augmented sites and (c) pristine and  
augmented sites, respectively [In PDF format, this table is best viewed in two-page mode]
(a)
Publication 
(year) Study design
Mean 
follow-
 up ± SD 
(years)
Number of 
subjects (n)
Mean 
age ± SD 
(years) Gender
Subject’s 
characteristics Group
Number of 
implants (n)
Implant system 
(s)
Type of 
restora-
tion
Type of 
augmenta-
tion
Timepoint of 
augmentation
Augmen tation  
material
Type of 
barrier 
membrane
Implant survival 
rate at subject 
level/implant 
level (%)
Implant 
failure rate at 
subject level/
implant level 
(%)
Confounding factors Biological complications
Comments
Subjects 
with a 
smoking 
history 
(%)
Subjects with 
a history of 
periodontal 
disease (%) FMPS (%)
% of 
subjects 
with SPT
Presence/
absence 
of KM
Case definition 
of peri- implant 
mucositis
Case 
definition of 
peri- 
implantitis
Mean bone 
level changes 
(mm) ± SD 
from Baseline
Mucositis at 
implant level/
subject level 
(%)
Peri- 
implantitis at 
implant level/
subject level 
(%)
Roccuzzo, 
Bonino, et al. 
(2014)
Prospective 
case series
10 32 43.3 ± 12.4 NR ASA type I- II 
partially 
edentulous
Periodontally 
healthy subjects
54 Institute 
Straumann AG
FDPs N N N N 100%/100% 0%/0% 15.60% 0 22.1 ± 10.8 59.40% NR BoP+ BL 
≤2 mm 
PPD>5 mm
BoP+, BL > 
2 mm 
PPD> 
5 mm
NR NR/15.6% NR/3.1% Personal 
communication 
Analysis at subject 
level46 53.3 ± 10.7 Subjects with 
moderate 
periodontitis
96 N N N 93.5%/96.9% 6.5%/3.1% 13% 100 27.7 ± 14.8 54.30% NR NR/36.9% NR/15.2%
45 52.7 ± 8.4 Subjects with 
severe 
periodontitis
102 N N N 93.4%/97.1% 6.6%/2.9% 22.20% 100 30.4 ± 20.6 68.90% NR NR/24.4% NR/42.2%
Donati et al. 
(2016)
Prospective 
case series
12 31 NR NR ASA type I- II 
partially 
edentulous
Pristine bone 35 Astra Tech SCs N N N N 89.7%/90.9% 10.3%/9.1% NR NR NR 100% NR BOP+ BoP+ and BL 
≥ 2 mm
0.67 ± 2.20 at 
subject level 
0.61 ± 2.10 
at implant 
level
25%/NR 8.6%/10% Subjects enrolled in 
SPT up to 5 years 
and then dismissed 
to dental provider 
for SPT in private 
practice
Zuffetti et al. 
(2016)
Randomized 
controlled
10 25 51.6 48% females 
52% males
ASA type I- II 
partially 
edentulous
Immediate loading 52 Zimmer Biomet 3i FDPs N N N N 96%/98.1% 4%/1.9% NR NR NR 100% NR Heavily 
inflamed soft 
tissue without 
BL
BL + 
suppura-
tion + 
heavily 
inflamed 
tissues
1.34 ± 0.55 at 
subject level
4%/12% 0%/0% Immediate implants 
with gap >1.5 mm 
were filled with 
DBBM 
Implants with 
peri- implantitis 
reported in early 
loading group did 
not present signs of 
inflammation at time 
of X- ray evaluation; 
however BL was 
overt
27 51.3 62% females 
48% males
Early loading 52 N N N N 100%/100% 0%/0% NR NR NR NR 1.42 ± 0.64 at 
subject level
0%/0% 3.8%/3.7%
Tenenbaum 
et al. (2017)
Prospective 
case series
10.8 ± 1.7 52 63 ± 9.23 63.5% (F) 
36.5% (M)
ASA type I- II 
partially 
edentulous
Pristine bone 108 Institute 
Straumann AG
FDPs N N N N 98.1%/99.1% 1.9%/0.9% 13% 84.61% 0.33 ± 0.67 100% NR BoP+ PPD>5 mm 
BoP+ 
BL>4.5 mm
NR 60.2%/73.1% 12%/15.4% Plaque Index based on 
Silness & Löe (1964)
(b)
Publication 
(year) Study design
Mean 
follow- up ± 
SD (years)
Number of 
subjects
Mean 
age ± SD 
(years) Gender
Subject’s 
characteristics Group
Number of 
implants Implant system
Type of 
restoration
Type of 
augmenta-
tion
Timepoint of 
augmenta-
tion Augmen tation material
Type of barrier 
membrane
Implant 
survival rate 
at subject 
level/implant 
level (%)
Implant failure 
rate at subject 
level/implant 
level (%)
Confounding factors Biological complications
Comments
Subjects 
with a 
smoking 
history (%)
Subjects 
with a 
history of 
periodontal 
disease (%) FMPS (%)
% of 
subjects 
with SPT
Presence/
absence of KM
Case definition 
of peri- implant 
mucositis
Case definition 
of 
peri- 
implantitis
Mean bone 
level changes 
(mm) ± SD 
from Baseline
Mucositis at 
subject level/
implant level 
(%)
Peri- 
implantitis at 
subject level/
implant level 
(%)
Roccuzzo, 
Gaudioso, 
et al. (2014)
Prospective 
case– control
10 19 48.4 37.85% 
females 
62.15% 
males
ASA type I- II 
partially 
edentulous
ARP 19 Institute 
Straumann 
AG
SCs ARP At tooth 
extraction
DBBM Collagen 100%/100% 0%/0% 5.20% NR 24.4 ± 
6.6%
100% 3.68 ± 1.11 mm BoP+ BL 
≤2 mm 
PPD>5 mm
BoP+ 
BL>2 mm 
PPD>5 mm
0.21 ± 0.42 
subject level
5.2%/5.2% 0%/0% Patients were 
prospectively 
evaluated 
but not 
randomized 
13.9% of the 
cases 
received 
additional 
buccal bony 
contour 
augmenta-
tion Systemic 
antibiotics 
were used to 
prevent 
post- surgical 
complica-
tions 2 
patients 
dropped out
15 47.2 47% 
females 
53% 
males
PB 15 N N N 100%/100% 0%/0% 20% 21.5 ± 
8.1%
3.93 ± 0.8 mm 0.20 ± 0.32 
subject level
6.6%/6.6% 0%/0%
Roccuzzo 
et al. (2017)
Prospective 
case series
10 34 48.5 ± 10.6 71% 
females 
29% 
males
ASA type I- II 
partially 
edentulous
GBR 68 Institute 
Straumann 
AG
FDPs VRA Before 
implant 
placement
Autogenous bone block  
and particulated  
autogenous bone
Titanium- 
reinforced 
ePTFE or 
Titanium mesh
88.2/94.1% 11.8/5.9% NR PHP (53%) PHP 
(26.4%)
100% 1.89 ± 1.11 mm BOP+ BL 
≤2 mm 
PD>5 mm
BOP+ 
BL>2 mm 
PD>5 mm
PHP: 
0.43 ± 0.50
20.6%/10.3% 32.3%/16.2% 7 patients with 
14 implants 
dropped out
PCP (47%) PCP 
(15.7%)
PCP: 
0.78 ± 0.59
Simion et al. 
(2016)
Retrospec tive 
case series
15 (range: 
13–21 
years)
33 62 30% 
females 
70% 
males
Systemic 
conditions 
NR partially 
edentulous
GBR 91 Nobel Biocare FDPs VRA Before 
implant 
placement
Autogenous bone or  
blood clot and DBBM
Titanium- 
reinforced 
ePTFE
89.9%/96.7 9.1/3.3% 27% 18% 54% 30% 72% Inflammation 
of the 
peri- implant 
mucosa 
without 
discernible 
progressing 
BL
Infection with 
suppuration 
associated 
with clinically 
significant 
progressing 
BL after the 
adaptive 
phase
1.02 ± 1.47 
implant 
level
60.6%/44% 15.2%/9.9%
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TABLE  2 Characteristics of the included studies on implants placed in (a) pristine sites, (b) augmented sites and (c) pristine and  
augmented sites, respectively [In PDF format, this table is best viewed in two-page mode]
(a)
Publication 
(year) Study design
Mean 
follow-
 up ± SD 
(years)
Number of 
subjects (n)
Mean 
age ± SD 
(years) Gender
Subject’s 
characteristics Group
Number of 
implants (n)
Implant system 
(s)
Type of 
restora-
tion
Type of 
augmenta-
tion
Timepoint of 
augmentation
Augmen tation  
material
Type of 
barrier 
membrane
Implant survival 
rate at subject 
level/implant 
level (%)
Implant 
failure rate at 
subject level/
implant level 
(%)
Confounding factors Biological complications
Comments
Subjects 
with a 
smoking 
history 
(%)
Subjects with 
a history of 
periodontal 
disease (%) FMPS (%)
% of 
subjects 
with SPT
Presence/
absence 
of KM
Case definition 
of peri- implant 
mucositis
Case 
definition of 
peri- 
implantitis
Mean bone 
level changes 
(mm) ± SD 
from Baseline
Mucositis at 
implant level/
subject level 
(%)
Peri- 
implantitis at 
implant level/
subject level 
(%)
Roccuzzo, 
Bonino, et al. 
(2014)
Prospective 
case series
10 32 43.3 ± 12.4 NR ASA type I- II 
partially 
edentulous
Periodontally 
healthy subjects
54 Institute 
Straumann AG
FDPs N N N N 100%/100% 0%/0% 15.60% 0 22.1 ± 10.8 59.40% NR BoP+ BL 
≤2 mm 
PPD>5 mm
BoP+, BL > 
2 mm 
PPD> 
5 mm
NR NR/15.6% NR/3.1% Personal 
communication 
Analysis at subject 
level46 53.3 ± 10.7 Subjects with 
moderate 
periodontitis
96 N N N 93.5%/96.9% 6.5%/3.1% 13% 100 27.7 ± 14.8 54.30% NR NR/36.9% NR/15.2%
45 52.7 ± 8.4 Subjects with 
severe 
periodontitis
102 N N N 93.4%/97.1% 6.6%/2.9% 22.20% 100 30.4 ± 20.6 68.90% NR NR/24.4% NR/42.2%
Donati et al. 
(2016)
Prospective 
case series
12 31 NR NR ASA type I- II 
partially 
edentulous
Pristine bone 35 Astra Tech SCs N N N N 89.7%/90.9% 10.3%/9.1% NR NR NR 100% NR BOP+ BoP+ and BL 
≥ 2 mm
0.67 ± 2.20 at 
subject level 
0.61 ± 2.10 
at implant 
level
25%/NR 8.6%/10% Subjects enrolled in 
SPT up to 5 years 
and then dismissed 
to dental provider 
for SPT in private 
practice
Zuffetti et al. 
(2016)
Randomized 
controlled
10 25 51.6 48% females 
52% males
ASA type I- II 
partially 
edentulous
Immediate loading 52 Zimmer Biomet 3i FDPs N N N N 96%/98.1% 4%/1.9% NR NR NR 100% NR Heavily 
inflamed soft 
tissue without 
BL
BL + 
suppura-
tion + 
heavily 
inflamed 
tissues
1.34 ± 0.55 at 
subject level
4%/12% 0%/0% Immediate implants 
with gap >1.5 mm 
were filled with 
DBBM 
Implants with 
peri- implantitis 
reported in early 
loading group did 
not present signs of 
inflammation at time 
of X- ray evaluation; 
however BL was 
overt
27 51.3 62% females 
48% males
Early loading 52 N N N N 100%/100% 0%/0% NR NR NR NR 1.42 ± 0.64 at 
subject level
0%/0% 3.8%/3.7%
Tenenbaum 
et al. (2017)
Prospective 
case series
10.8 ± 1.7 52 63 ± 9.23 63.5% (F) 
36.5% (M)
ASA type I- II 
partially 
edentulous
Pristine bone 108 Institute 
Straumann AG
FDPs N N N N 98.1%/99.1% 1.9%/0.9% 13% 84.61% 0.33 ± 0.67 100% NR BoP+ PPD>5 mm 
BoP+ 
BL>4.5 mm
NR 60.2%/73.1% 12%/15.4% Plaque Index based on 
Silness & Löe (1964)
(b)
Publication 
(year) Study design
Mean 
follow- up ± 
SD (years)
Number of 
subjects
Mean 
age ± SD 
(years) Gender
Subject’s 
characteristics Group
Number of 
implants Implant system
Type of 
restoration
Type of 
augmenta-
tion
Timepoint of 
augmenta-
tion Augmen tation material
Type of barrier 
membrane
Implant 
survival rate 
at subject 
level/implant 
level (%)
Implant failure 
rate at subject 
level/implant 
level (%)
Confounding factors Biological complications
Comments
Subjects 
with a 
smoking 
history (%)
Subjects 
with a 
history of 
periodontal 
disease (%) FMPS (%)
% of 
subjects 
with SPT
Presence/
absence of KM
Case definition 
of peri- implant 
mucositis
Case definition 
of 
peri- 
implantitis
Mean bone 
level changes 
(mm) ± SD 
from Baseline
Mucositis at 
subject level/
implant level 
(%)
Peri- 
implantitis at 
subject level/
implant level 
(%)
Roccuzzo, 
Gaudioso, 
et al. (2014)
Prospective 
case– control
10 19 48.4 37.85% 
females 
62.15% 
males
ASA type I- II 
partially 
edentulous
ARP 19 Institute 
Straumann 
AG
SCs ARP At tooth 
extraction
DBBM Collagen 100%/100% 0%/0% 5.20% NR 24.4 ± 
6.6%
100% 3.68 ± 1.11 mm BoP+ BL 
≤2 mm 
PPD>5 mm
BoP+ 
BL>2 mm 
PPD>5 mm
0.21 ± 0.42 
subject level
5.2%/5.2% 0%/0% Patients were 
prospectively 
evaluated 
but not 
randomized 
13.9% of the 
cases 
received 
additional 
buccal bony 
contour 
augmenta-
tion Systemic 
antibiotics 
were used to 
prevent 
post- surgical 
complica-
tions 2 
patients 
dropped out
15 47.2 47% 
females 
53% 
males
PB 15 N N N 100%/100% 0%/0% 20% 21.5 ± 
8.1%
3.93 ± 0.8 mm 0.20 ± 0.32 
subject level
6.6%/6.6% 0%/0%
Roccuzzo 
et al. (2017)
Prospective 
case series
10 34 48.5 ± 10.6 71% 
females 
29% 
males
ASA type I- II 
partially 
edentulous
GBR 68 Institute 
Straumann 
AG
FDPs VRA Before 
implant 
placement
Autogenous bone block  
and particulated  
autogenous bone
Titanium- 
reinforced 
ePTFE or 
Titanium mesh
88.2/94.1% 11.8/5.9% NR PHP (53%) PHP 
(26.4%)
100% 1.89 ± 1.11 mm BOP+ BL 
≤2 mm 
PD>5 mm
BOP+ 
BL>2 mm 
PD>5 mm
PHP: 
0.43 ± 0.50
20.6%/10.3% 32.3%/16.2% 7 patients with 
14 implants 
dropped out
PCP (47%) PCP 
(15.7%)
PCP: 
0.78 ± 0.59
Simion et al. 
(2016)
Retrospec tive 
case series
15 (range: 
13–21 
years)
33 62 30% 
females 
70% 
males
Systemic 
conditions 
NR partially 
edentulous
GBR 91 Nobel Biocare FDPs VRA Before 
implant 
placement
Autogenous bone or  
blood clot and DBBM
Titanium- 
reinforced 
ePTFE
89.9%/96.7 9.1/3.3% 27% 18% 54% 30% 72% Inflammation 
of the 
peri- implant 
mucosa 
without 
discernible 
progressing 
BL
Infection with 
suppuration 
associated 
with clinically 
significant 
progressing 
BL after the 
adaptive 
phase
1.02 ± 1.47 
implant 
level
60.6%/44% 15.2%/9.9%
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TABLE  2  (additional columns)
302  |     SALVI et AL.
3.4.3 | Implant failure
The total number of patients observed was 352, 273 for pristine 
sites and 79 for augmented sites. The prevalence of implant failure 
at patient level was estimated to a weighted mean of 2.5% (95% CI 
1%–4%) for pristine sites and of 3.6% (95% CI 0%–8%) for augmented 
sites. Heterogeneity as expressed by the I2 test was 0% in both pristine 
and augmented sites, respectively (Figure 4).
3.5 | Meta- analyses at implant level
3.5.1 | Peri- implant mucositis
The total number of implants observed was 642, 415 for pristine 
sites and 227 for augmented sites. The prevalence of peri- implant 
mucositis at implant level presented a weighted mean value of 21.2% 
(95% CI 4%–38%) for pristine sites and of 24.6% (95% CI 6%–44%) 
for augmented sites. Heterogeneity as expressed by the I2 test was 
97% for pristine and 93% for augmented sites, respectively (Figure 5).
3.5.2 | Peri- implantitis
The total number of implants observed was 642, 415 for pristine 
sites and 227 for augmented sites. The prevalence of peri- implantitis 
at implant level presented a weighted mean value of 7.5% (95% 
CI 2%–13%) for pristine sites and of 9.7% (95% CI 4%–15%) for 
augmented sites. Heterogeneity as expressed by the I2 test was 84% 
for pristine and 56% for augmented sites, respectively (Figure 6).
3.5.3 | Implant failure
The total number of implants observed was 739, 667 for pristine 
sites and 72 for augmented sites. The prevalence of failure at implant 
level presented a weighted mean value of 2.4% (95% CI 1%–4%) for 
pristine sites and of 6.5% (95% CI 0%–15%) for augmented sites. 
Heterogeneity as expressed by the I2 test was 34% for pristine and 
60% for augmented sites, respectively (Figure 7).
Collectively, as indicated in the Forest plots by the overlap of the 95% 
confidence intervals, no statistically significant differences (p > .05) were 
observed between implants placed in pristine vs. augmented sites for 
any outcome variables both at patient and at implant levels, respectively.
3.6 | Quality assessment
Five case- series studies (Donati et al., 2016; Roccuzzo, Bonino, et al., 
2014; Roccuzzo et al. 2017; Simion et al., 2016; Tenenbaum et al., 
2017), one case–control (Roccuzzo, Gaudioso, et al., 2014) and one 
cross- sectional study (Daubert et al., 2015) were assessed by means 
of the NOS (Wells et al., 2011). The mean ± standard deviation (SD) 
NOS score was 4.8 ± 1.8 for “selection” (median: 4, interquartile range 
(c)
Publication 
(year)
Study 
design
Mean 
follow- and 
range (years)
Number of 
subjects (n)
Mean 
age ± SD 
(years) at 
follow- up Gender
Subject’s 
characteristics Group
Number of 
implants (n)
Implant 
system (s)
Type of 
restoration
Type of 
regeneration
Timepoint of 
augmentation Augmentation material
Type of 
barrier 
membrane
Implant 
survival rate 
at subject 
level/implant 
level (%)
Implant failure 
rate at subject 
level/implant 
level (%)
Confounding factors Biological complications
Comments
Subjects with 
a smoking 
history (%)
Subjects with 
a history of 
periodontal 
disease (%)
FMPS 
(%)
% of subjects 
with SPT
Presence/
absence of 
KM
Case 
definition of 
peri- implant 
mucositis
Case 
definition of 
peri- 
implantitis
Mean bone 
level changes 
(mm) ± SD 
from Baseline
Mucositis at 
subject level/
implant level 
(%)
Peri- 
implantitis at 
subject level/
implant level 
(%)
Pristine 
bone
153 N N N N NR/91.5% NR/8.5% NR NR NR NR/30.7% NR/17.6%
Daubert 
et al. 
(2015)
Cross- 
sectional
10.9 ± 1.5 
(8.9–14.8)
96 67.6 ± 10.6 50% 
females 
50% 
males
Systemic 
conditions 
NR Partially 
and fully 
edentulous
Augmented 
bone
53 Zimmer 
Biomet 3i, 
Institute 
Straumann 
AG, Nobel 
Biocare, 
Brånemark 
System, 
Centerpulse 
Dental, 
Astra Tech, 
Sulzer 
Dental, 
Steri- Oss
Cement- 
retained 
(69.4%)/
screw- 
retained 
(30.6%) 
FDPs
NR NR Biogran®, BioOss®,  
AB, Osseograft™,  
DFDBA, BioOss® mixed  
with Puros®, BioOss®  
mixed with AB
Biomend® NR/88.7% NR/11.3% 5.60% NR NR 84.37% NR BoP+ and/or 
inflammation
BoP+ and/or 
suppuration 
and BL ≥ 
2 mm after 
remodelling 
and PPD ≥ 
4 mm
NR NR/39.6% NR/11.3% Author was 
contacted
AB, autogenous bone; ARP, alveolar ridge preservation; ASA, American Society of Anaesthesiology; BL, bone loss; BoP, Bleeding on Probing;  
DBBM, deproteinized bovine bone mineral; DFDBA, demineralized freeze- dried bone allograft; ePTFE, expanded Poly- Tetra- Fluor- Ethylene;  
FDP, fixed dental prosthesis; FMPS, full- mouth plaque score; GBR, guided bone regeneration; KM, keratinized mucosa; N, none; NR,  
not reported; PB, pristine bone; PCP, periodontally compromised patient; PHP, periodontally healthy patient; PPD, pocket probing depth;  
SC, single- unit crown; SD, standard deviation; SLA, sandblasted and acid- etched; SPT, supportive periodontal therapy; VRA, vertical ridge augmentation.
Astra Tech, Mölndal, Sweden; Biogran, Biomet 3i, Palm Beach Gardens, FL, USA; Biomend, Zimmer Biomet Dental, Warsaw, IN, USA.; BioOss,  
Geistlich Biomaterials, Wolhusen, Switzerland; Brånemark System, Nobel Biocare, Gothenburg, Sweden; Centerpulse Dental, Carlsbad, CA, USA;  
Institute Straumann AG, Basel, Switzerland; Nobel Biocare, Gothenburg, Sweden; Osseograft, Advanced Biotech Products Ltd., Chennai, India;  
Puros, Zimmer Biomet Dental, Warsaw, IN, USA; Steri- Oss, Nobel Biocare, Gothenburg, Sweden; Sulzer Dental, Carlsbad, CA, USA; Zimmer  
Biomet 3i, Palm Beach Gardens, FL, USA.
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[IQR]: 0), 2.6 ± 1.6 for “comparability” (median: 1, IQR: 0) and 3.8 ± 2.8 
for “exposure/outcome” (median: 3, IQR: 0.5) (Table 3).
One randomized clinical trial (Zuffetti et al., 2016) was scored 
according to the randomized clinical trial checklist of the Cochrane 
Center and the CONSORT (Consolidated Standards of Reporting Trials) 
statement. Two points were given to “selection of bias,” one to “detec-
tion of bias” and one to “reporting bias” (Table 4).
4  | DISCUSSION
The aim of the present systematic review was to investigate and 
compare the prevalence of biological complications and failure of 
implants placed in pristine sites vs. augmented sites after a mean 
observation period of at least 10 years. The outcomes of the meta- 
analysis failed to reveal any statistically significant differences 
F IGURE  2 Forest plot of the weighted mean prevalence of peri- implant mucositis at patient level of implants placed in pristine vs. 
augmented sites
(c)
Publication 
(year)
Study 
design
Mean 
follow- and 
range (years)
Number of 
subjects (n)
Mean 
age ± SD 
(years) at 
follow- up Gender
Subject’s 
characteristics Group
Number of 
implants (n)
Implant 
system (s)
Type of 
restoration
Type of 
regeneration
Timepoint of 
augmentation Augmentation material
Type of 
barrier 
membrane
Implant 
survival rate 
at subject 
level/implant 
level (%)
Implant failure 
rate at subject 
level/implant 
level (%)
Confounding factors Biological complications
Comments
Subjects with 
a smoking 
history (%)
Subjects with 
a history of 
periodontal 
disease (%)
FMPS 
(%)
% of subjects 
with SPT
Presence/
absence of 
KM
Case 
definition of 
peri- implant 
mucositis
Case 
definition of 
peri- 
implantitis
Mean bone 
level changes 
(mm) ± SD 
from Baseline
Mucositis at 
subject level/
implant level 
(%)
Peri- 
implantitis at 
subject level/
implant level 
(%)
Pristine 
bone
153 N N N N NR/91.5% NR/8.5% NR NR NR NR/30.7% NR/17.6%
Daubert 
et al. 
(2015)
Cross- 
sectional
10.9 ± 1.5 
(8.9–14.8)
96 67.6 ± 10.6 50% 
females 
50% 
males
Systemic 
conditions 
NR Partially 
and fully 
edentulous
Augmented 
bone
53 Zimmer 
Biomet 3i, 
Institute 
Straumann 
AG, Nobel 
Biocare, 
Brånemark 
System, 
Centerpulse 
Dental, 
Astra Tech, 
Sulzer 
Dental, 
Steri- Oss
Cement- 
retained 
(69.4%)/
screw- 
retained 
(30.6%) 
FDPs
NR NR Biogran®, BioOss®,  
AB, Osseograft™,  
DFDBA, BioOss® mixed  
with Puros®, BioOss®  
mixed with AB
Biomend® NR/88.7% NR/11.3% 5.60% NR NR 84.37% NR BoP+ and/or 
inflammation
BoP+ and/or 
suppuration 
and BL ≥ 
2 mm after 
remodelling 
and PPD ≥ 
4 mm
NR NR/39.6% NR/11.3% Author was 
contacted
AB, autogenous bone; ARP, alveolar ridge preservation; ASA, American Society of Anaesthesiology; BL, bone loss; BoP, Bleeding on Probing;  
DBBM, deproteinized bovine bone mineral; DFDBA, demineralized freeze- dried bone allograft; ePTFE, expanded Poly- Tetra- Fluor- Ethylene;  
FDP, fixed dental prosthesis; FMPS, full- mouth plaque score; GBR, guided bone regeneration; KM, keratinized mucosa; N, none; NR,  
not reported; PB, pristine bone; PCP, periodontally compromised patient; PHP, periodontally healthy patient; PPD, pocket probing depth;  
SC, single- unit crown; SD, standard deviation; SLA, sandblasted and acid- etched; SPT, supportive periodontal therapy; VRA, vertical ridge augmentation.
Astra Tech, Mölndal, Sweden; Biogran, Biomet 3i, Palm Beach Gardens, FL, USA; Biomend, Zimmer Biomet Dental, Warsaw, IN, USA.; BioOss,  
Geistlich Biomaterials, Wolhusen, Switzerland; Brånemark System, Nobel Biocare, Gothenburg, Sweden; Centerpulse Dental, Carlsbad, CA, USA;  
Institute Straumann AG, Basel, Switzerland; Nobel Biocare, Gothenburg, Sweden; Osseograft, Advanced Biotech Products Ltd., Chennai, India;  
Puros, Zimmer Biomet Dental, Warsaw, IN, USA; Steri- Oss, Nobel Biocare, Gothenburg, Sweden; Sulzer Dental, Carlsbad, CA, USA; Zimmer  
Biomet 3i, Palm Beach Gardens, FL, USA.
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between implants placed in pristine and augmented sites for any 
outcome variables both at patient and implant levels, respectively. 
Nevertheless, patients receiving implants in augmented sites 
displayed higher variability and lower predictability in terms of peri-
implantitis compared with patients receiving implants in pristine 
sites. Even though the meta- analysis yielded its weakness from 
an outcome point of view, it had the merit to highlight the high 
heterogeneity and the limited number of studies available on this 
topic. Moreover, a great variability in terms of patient sampling, 
case definitions and eligibility criteria was observed. In fact, the 
studies included in the present systematic review did not directly 
address the focused questions or reported prospectively data on 
cohorts of patients treated with implants placed in augmented vs. 
pristine sites but reported on patients in need of implant therapy 
based on different eligibility criteria and case definitions. From a 
methodological point of view, another shortcoming of the present 
systematic review was the impossibility to identify randomized con-
trolled trials (RCTs) complying with ethical guidelines. The avoidance 
of augmentation procedures in cases considered necessary is in con-
trast with the ethical principle of maintaining the same standard of 
care for all patients.
This limitation was overcome in a randomized controlled trial by 
selecting implants of different length in cases of vertical bone aug-
mentation in the anterior mandible followed by prosthetic rehabilita-
tion with an overdenture (Visser et al., 2016). The results of that RCT, 
however, indicated that implants with a length of 13–18 mm placed in 
mandibular sites augmented with anterior iliac crest yielded a signifi-
cantly lower survival rate (88.7%) compared with that of implants with 
a length of 8–11 mm placed in pristine bone (98.7%) up to 15 years 
(Visser et al., 2016). Hence, these outcomes (Visser et al., 2016) are 
in partial agreement with the findings of the present systematic re-
view as even though the meta- analysis failed to show statistical signif-
icance, failure rate was higher for implants placed in augmented sites 
compared with pristine sites.
It was observed that only three of eight studies included in the pres-
ent systematic review reported data on the history of treated periodonti-
tis prior to implant placement (Roccuzzo, Bonino, et al., 2014; Roccuzzo 
et al. 2017; Simion et al., 2016). This might stand for one of the reasons 
of the high variability of the outcomes in the present systematic review 
as history of periodontal disease is regarded as the major risk factor for 
peri- implantitis (Derks et al., 2016; Sanz & Chapple, 2012). Findings 
from several studies indicated that patients treated for chronic or ag-
gressive periodontitis may experience more biological complications 
and implant failures compared with non- periodontitis patients (Aguirre- 
Zorzano et al., 2015; Derks et al., 2016; Monje et al., 2014; Sgolastra, 
Petrucci, Severino, Gatto, & Monaco, 2015; Sousa et al., 2016). In fact, 
outcomes of a recent publication on the effectiveness of implant ther-
apy in a Swedish population sample indicated that significantly higher 
odds ratios (ORs) for moderate/severe peri- implantitis were found for 
patients diagnosed with periodontitis (OR 4.08) compared with peri-
odontally healthy patients (Derks et al., 2016).
Moreover, the endpoints of periodontal therapy were shown to 
impact on the survival and success rates of dental implants (Pjetursson 
et al., 2012). The presence of residual pocket probing depths ≥5 mm 
and bleeding on probing scores ≥ 30% at the end of active periodon-
tal therapy represented a significant risk of peri- implantitis and im-
plant loss over a mean follow- up period of 7.9 years (Pjetursson et al., 
2012). In addition, patients adhering to regular supportive periodontal 
therapy (SPT) and developing periodontal re- infections were at greater 
risk of peri- implantitis and implant failure compared with periodontally 
stable patients (Monje et al., 2016, 2017; Pjetursson et al., 2012).
All studies included in the present systematic review reported on 
the enrolment of patients in SPT following implant therapy. In this re-
spect, it is well established that patients not enrolled in regular SPT 
suffer from higher prevalence of peri- implantitis and implant failure 
compared with patients enrolled in SPT (Monje et al., 2016; Roccuzzo, 
Bonino, et al., 2014; Rokn et al., 2017; Salvi & Zitzmann, 2014).
F IGURE  3 Forest plot of the weighted mean prevalence of peri- implantitis at patient level of implants placed in pristine vs. augmented sites
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F IGURE  6 Forest plot of the weighted mean prevalence of peri- implantitis at implant level of implants placed in pristine vs. augmented sites
F IGURE  5 Forest plot of the weighted mean prevalence of peri- implant mucositis at implant level of implants placed in pristine vs. 
augmented sites
F IGURE  4 Forest plot of the weighted mean prevalence of failure at patient level of implants placed in pristine vs. augmented sites
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Different augmentation techniques (e.g., alveolar ridge preserva-
tion or vertical ridge augmentation), different materials (e.g., autoge-
nous bone or bone substitutes) and different barrier membranes (e.g., 
resorbable and non- resorbable) were used in the four studies report-
ing on implant placement in augmented sites (Daubert et al., 2015; 
Roccuzzo, Gaudioso, et al., 2014; Roccuzzo et al. 2017; Simion et al., 
2016). Hence, the variety of materials and protocols used for bone 
augmentation could not be assessed in the meta- analysis but it may be 
assumed that it plays a role on the long- term prevalence of biological 
complications and implant failure reported in the present systematic 
review. Findings from a recent systematic review yielded a comparable 
risk for wound healing complications when using resorbable (18.3%) vs. 
non- resorbable membranes (17.6%) (Lim, Lin, Monje, Chan, & Wang, 
2017). Nevertheless, it is known that non- exposed sites achieve a six-
fold greater bone gain compared with augmented sites where wound 
dehiscence occurred (Machtei, 2001). Hence, findings from the pres-
ent systematic review should be interpreted with caution due to the 
impossibility to perform subset analysis to gain insight on the impact 
of the augmentation procedure and/or biomaterials on the prevalence 
of peri- implant diseases.
5  | LIMITATIONS
Despite a comprehensive and strict screening process, some limitations 
might bias the outcomes of the present systematic review. Firstly, 
to the best of the authors’ knowledge, no randomized controlled 
trials complying with ethical principles in cases where augmentation 
procedures were considered mandatory could be identified. Secondly, 
the included studies did not directly address the focused questions 
F IGURE  7 Forest plot of the weighted mean prevalence of failure at implant level of implants placed in pristine vs. augmented sites
Publication Selection Comparability Exposure/outcome
Roccuzzo, Bonino, et al. 
(2014)
★★★★ ★★ ★★★★
Tenenbaum et al. (2017) ★★★★ ★ ★
Donati et al. (2016) ★★★ ★ ★★★
Simion et al. (2016) ★★★★ ★ ★★
Roccuzzo, Gaudioso, et al. 
(2014)
★★★★★ ★ ★★★
Roccuzzo et al. (2017) ★★★★ ★ ★★★
Daubert et al. (2015) ★★★★ ★ ★★★
TABLE  3 Newcastle- Ottawa Scale for 
assessing the quality of non- randomized, 
non- interventional studies
TABLE  4 Parameters provided in the Cochrane Center and CONSORT guidelines (Consolidated Standards of Reporting Trials) to evaluate 
the quality of randomized controlled trials (RCTs)
Publication Selection of bias Performance of bias Detection of bias Attrition bias Reporting bias Other bias
Zuffetti et al. (2016) ★★ ★ ★
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but reported on patients in need of implant therapy based on different 
eligibility criteria and case definitions of biological complications and 
more importantly, not controlling for other confounders. Lastly, the 
meta- analysis highlighted the high heterogeneity and the limited number 
of studies fulfilling the inclusion criteria of the present systematic review.
Patient samples in the included studies were quite varied, differ-
ing with respect to clinical characteristics such as history of treated 
periodontitis and materials used for augmentation procedures. In ad-
dition, it should be highlighted that none of the four studies including 
augmentation procedures adopted the same technique, enhancing the 
heterogeneity due to sample selection. Therefore, results from the 
meta- analysis should be interpreted with caution, also considering the 
lack of representation of different augmentation techniques used and 
of the variety of implant designs available, resulting in a lack of gener-
alizability of the results.
6  | FUTURE DIRECTIONS
The conduction of case–control studies in which patients with implants 
placed in augmented sites are matched with patients receiving implants 
in pristine sites and are prospectively evaluated should be encouraged. A 
higher level of evidence should include the performance of prospective 
cohort multi- centre studies in which patients in need of implants 
with augmentation procedures are recruited, treated according to 
standardized protocols and a priori- determined materials and enrolled 
in regular long- term maintenance to better capture the onset of disease.
7  | CONCLUSIONS
The studies included in the present systematic review did not directly 
address the focused questions. Hence, the outcomes of the meta- 
analysis should be interpreted with caution due to high variability with 
respect to patient sampling, case definitions of biological complications 
and eligibility criteria. Nevertheless, within the limitations of the 
present systematic review, patients receiving implants in augmented 
sites displayed higher variability and lower predictability in terms of 
peri-implantitis compared with patients receiving implants in pristine 
sites. Accordingly, future clinical trials should investigate the impact of 
augmentation procedures on implant outcomes controlling for other 
potential confounders and standardizing the alveolar bony defects.
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